EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis

Flavia Fontana, Giuseppina Molinaro, Sofia Moroni, Giulia Pallozzi, Mónica P A Ferreira, Rubén Pareja Tello, Khalil Elbadri, Giulia Torrieri, Alexandra Correia, Marianna Kemell, Luca Casettari, Christian Celia und 1 weitere

Advanced Healthcare Materials · 2024-06 · 13 (15)

DOI: 10.1002/adhm.202302074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 24.03.2024. Verfasst von Flavia Fontana und 12 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland. Hauptthemen laut MEDLINE: Curcumin, Atherosclerosis, Nanoparticles, Blood Platelets. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UMCG Research Funds, European Union - NextGenerationEU - under the Italian Ministry of University and Research (MUR), H2020 Marie Skłodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis still represents a major driver of cardiovascular diseases worldwide. Together with accumulation of lipids in the plaque, inflammation is recognized as one of the key players in the formation and development of atherosclerotic plaque. Systemic anti‐inflammatory treatments are successful in reducing the disease burden, but are correlated with severe side effects, underlining the need for targeted formulations. In this work, curcumin is chosen as the anti‐inflammatory payload model and further loaded in lignin‐based nanoparticles (NPs). The NPs are then coated with a tannic acid (TA)− Fe (III) complex and further cloaked with fragments derived from platelet cell membrane, yielding NPs with homogenous size. The two coatings increase the interaction between the NPs and cells, both endothelial and macrophages, in steady state or inflamed status. Furthermore, NPs are cytocompatible toward endothelial, smooth muscle and immune cells, while not inducing immune activation. The anti‐inflammatory efficacy is demonstrated in endothelial cells by real‐time quantitative polymerase chain reaction and ELISA assay where curcumin‐loaded NPs decrease the expression of Nf‐ κb, TGF‐β1, IL‐6, and IL‐1β in lipopolysaccharide‐inflamed cells. Overall, due to the increase in the cell−NP interactions and the anti‐inflammatory efficacy, these NPs represent potential candidates for the targeted anti‐inflammatory treatment of atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminAtherosclerosisNanoparticlesBlood PlateletsAnti-Inflammatory AgentsHumansAnimalsBiomimetic MaterialsHuman Umbilical Vein Endothelial CellsTanninsRAW 264.7 CellsMiceMacrophages

Stichwörter der Autor:innen

anti‐inflammatoryatherosclerosisbiohybridnanoparticlesplatelets membrane

Substanzen

CurcuminAnti-Inflammatory AgentsTannins

Autor:innen und Institutionen

  • Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, FI-00014, Finland.
  • Department of Biomolecular Sciences, School of Pharmacy, University of Urbino Carlo Bo, Urbino, I-61029, Italy.
  • Department of Pharmacy, University of Chieti-Pescara "G. D'Annunzio", Via dei Vestini 13, Chieti, I-66100, Italy.
  • Department of Chemistry, University of Helsinki, Helsinki, FI-00014, Finland.
  • Institute of Nanochemistry and Nanobiology, School of Environmental and Chemical Engineering, Shanghai University, Shanghai, 200444, P. R. China.
  • Laboratory of Drug Targets Histopathology, Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, LT-44307, Lithuania.

ORCID-Profile: Hélder A Santos

Förderung

  • UMCG Research Funds
  • European Union - NextGenerationEU - under the Italian Ministry of University and Research (MUR)
  • H2020 Marie Skłodowska-Curie Actions
  • H2020 European Research Council
  • Business Finland
  • Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta
  • Erasmus+

Zitieren

APA

Fontana, F., Molinaro, G., Moroni, S., Pallozzi, G., Ferreira, M. P. A., Tello, R. P., Elbadri, K., Torrieri, G., Correia, A., Kemell, M., Casettari, L., Celia, C., & Santos, H. A. (2024). Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis. Advanced Healthcare Materials, 13(15). https://doi.org/10.1002/adhm.202302074

Vancouver

Fontana F, Molinaro G, Moroni S, Pallozzi G, Ferreira MPA, Tello RP, et al. Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis. Advanced Healthcare Materials. 2024;13(15). doi:10.1002/adhm.202302074

BibTeX
@article{Fontana2024,
  author = {Fontana, Flavia and Molinaro, Giuseppina and Moroni, Sofia and Pallozzi, Giulia and Ferreira, Mónica P A and Tello, Rubén Pareja and Elbadri, Khalil and Torrieri, Giulia and Correia, Alexandra and Kemell, Marianna and Casettari, Luca and Celia, Christian and Santos, Hélder A},
  title = {Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {15},
  doi = {10.1002/adhm.202302074}
}
Kostenlos starten →